Ionis Pharmaceuticals, Inc. (LON:0JDI)

Ionis Pharmaceuticals Statistics

Total Valuation

LON:0JDI has a market cap or net worth of GBP 10.01 billion. The enterprise value is 9.88 billion.

Market Cap	10.01B
Enterprise Value	9.88B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	161.97M
Shares Outstanding	n/a
Shares Change (YoY)	+8.89%
Shares Change (QoQ)	-12.38%
Owned by Insiders (%)	0.83%
Owned by Institutions (%)	105.98%
Float	160.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.92
PB Ratio	21.78
P/TBV Ratio	21.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-51.80
EV / Sales	13.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-43.87

Financial Position

The company has a current ratio of 2.79, with a Debt / Equity ratio of 3.33.

Current Ratio	2.79
Quick Ratio	2.51
Debt / Equity	3.33
Debt / EBITDA	n/a
Debt / FCF	-6.80
Interest Coverage	-3.07

Financial Efficiency

Return on equity (ROE) is -40.04% and return on invested capital (ROIC) is -73.48%.

Return on Equity (ROE)	-40.04%
Return on Assets (ROA)	-5.68%
Return on Invested Capital (ROIC)	-73.48%
Return on Capital Employed (ROCE)	-13.06%
Weighted Average Cost of Capital (WACC)	5.48%
Revenue Per Employee	672,926
Profits Per Employee	-178,394
Employee Count	1,069
Asset Turnover	0.32
Inventory Turnover	45.90

Taxes

Income Tax	-1.77M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +166.44% in the last 52 weeks. The beta is 0.28, so LON:0JDI's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+166.44%
50-Day Moving Average	80.82
200-Day Moving Average	58.40
Relative Strength Index (RSI)	54.57
Average Volume (20 Days)	620

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.55

Income Statement

In the last 12 months, LON:0JDI had revenue of GBP 719.36 million and -190.70 million in losses. Loss per share was -1.20.

Revenue	719.36M
Gross Profit	54.84M
Operating Income	-206.85M
Pretax Income	-192.48M
Net Income	-190.70M
EBITDA	-198.48M
EBIT	-206.85M
Loss Per Share	-1.20

Balance Sheet

The company has 1.67 billion in cash and 1.53 billion in debt, with a net cash position of 136.85 million.

Cash & Cash Equivalents	1.67B
Total Debt	1.53B
Net Cash	136.85M
Net Cash Per Share	n/a
Equity (Book Value)	459.73M
Book Value Per Share	2.85
Working Capital	1.20B

Cash Flow

In the last 12 months, operating cash flow was -183.76 million and capital expenditures -41.40 million, giving a free cash flow of -225.16 million.

Operating Cash Flow	-183.76M
Capital Expenditures	-41.40M
Free Cash Flow	-225.16M
FCF Per Share	n/a

Margins

Gross margin is 7.62%, with operating and profit margins of -28.75% and -26.51%.

Gross Margin	7.62%
Operating Margin	-28.75%
Pretax Margin	-26.76%
Profit Margin	-26.51%
EBITDA Margin	-27.59%
EBIT Margin	-28.75%
FCF Margin	n/a

Dividends & Yields

LON:0JDI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.89%
Shareholder Yield	-8.89%
Earnings Yield	-1.90%
FCF Yield	-2.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0JDI has an Altman Z-Score of 1.05 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.05
Piotroski F-Score	4